Targeting inflammation to slow or delay functional decline: where are we?
Authors: Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, Pranno L, Guffanti EE, Bustacchini S, Lattanzio F
Date: 2010
Scope of interest: biogerontology
06 99 39
Recup number
You may also be interested in:
– Infiltrative treatment of tendinopathies with PRF: two years of experience of the SIMT of Frosinone
Authors: Maria Chiara De Nicolò (1) - Elena Gigliotti (1) - Giorgia Guiducci (1) - Deborah Ilaria Gadaleta (1) - Cristina D’Amico (1) - Francesca Chiarlitti (1) - Antonietta Arduini (1) - Gisella Brunetti (1) - Loredana Paniccia (1) - Bruna Giorgi (1) - Patrizia Tombolillo (1) - Domenico Castellitto (2) - Carla Gargiulo (1)
Date: 2020
Scope of interest: Clinical pathology
Read details
Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations.
Authors: Lapenta L, Morano A, Casciato S, Fanella M, Fattouch J, Vaudano AE, Gregori B, Vanacore N, Manfredi M, Giallonardo AT, Di Bonaventura C.
Date: 2014
Scope of interest: Epilepsy
Read details
Weak groups of the ABO system:incidence in the population related to the Frosinone SIMT in 2 years”
Authors: M.C.De Nicolò– C.D'Amico – F. Docimo - C.Gargiulo
Date: 2020
Scope of interest: CLINICAL PATHOLOGY
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
